Skip to main content

Icyo ugomba kumenya kuri kanseri y'ibere ifite inenge eshatu

Icyo ugomba kumenya kuri kanseri y'ibere ifite inenge eshatu

Ni ibisanzwe ko umuntu wese agira ubwoba gato iyo yumvise ijambo kanseri y'ibere. Ariko icy'ingenzi tugomba kumenya ni uko kanseri y'ibere yose atari imwe. Hari ubwoko butandukanye bwayo. Uyu munsi tugiye kuvuga ku bwoko bukunze kugaragara cyane kandi busaba kwitabwaho by'umwihariko mu gihe cyo kuvurwa. Iyi tuyita 'Kanseri y'ibere itatu' (TNBC mu magambo ahinnye). Kumva iri zina bishobora kumvikana nk'ibintu bigoye kuri wewe, ariko ntutinye. Tuzabivugaho mu buryo bworoshye, mu buryo ushobora kumva.

Kuki ibi byitwa 'Inyangingo eshatu'?

Reka dutangire n'icyo iri zina risobanura. Kugira ngo tubisobanukirwe, tugomba kugira igitekerezo gito ku buryo uturemangingo tusanzwe twa kanseri y'ibere dukora.

Tekereza ko uturemangingo mu mubiri wacu tumeze nk'inzugi. Izo nzugi zifite ingufuri zifata imfunguzo. Mu buvuzi, izi mfunguzo tuzita 'receptors'. Iyo imfunguzo zihuye n'izi mpuruza zije zigahuza, utwo turemangingo twakira ubutumwa runaka.

Hari ubwoko butatu bw'udukingirizo tw'umubiri (receptors) ingenzi cyane cyane muri kanseri y'ibere.

1. Uturemangingo twa Estrogen (ER): Ibi bifitanye isano na hormone ya estrogen y'abagore.

2. Uturemangingo twa Progesterone (PR): Ibi bifitanye isano n'indi misemburo y'abagore yitwa progesterone.

3. Utunyangingo twa HER2: Iyi ni receptor ifatana na poroteyine yitwa HER2. Iyi poroteyine igenzura imikurire y'uturemangingo tw'ibere.

Mu bwoko bwinshi bwa kanseri y'ibere, imwe, ebyiri, cyangwa eshatu muri izi receptor ziba nyinshi cyane. Ibi bivuze ko izi hormone na poroteyine bifasha uturemangingo twa kanseri gukura. Ni nko kongeramo ibicanwa ku muriro. Rero iyo abaganga bavura izi kanseri, bibanda kuri izi receptor bakayiha imiti izibuza (ubuvuzi bugamije). Iyi miti ifunga izo 'mfunguzo'. Hanyuma uturemangingo twa kanseri ntitwongera kubona ubutumwa dukeneye kugira ngo dukure.

Mu magambo make, 'triple-negative' bivuze ko utwo turemangingo twa kanseri tudafite resepteur eshatu zavuzwe haruguru (estrogen, progesterone, na HER2) . 'Negative' bivuze 'oya'. Ni 'triple-negative' kuko idafite zose uko ari eshatu.

Noneho ushobora kuba usobanukiwe aho ikibazo kiri? Imiti isanzwe yibasira receptor ntabwo ikora kuri ubwo bwoko bwa kanseri. Kuko nta receptor igomba kwibasira. Iki ni cyo kibazo gikomeye kuri kanseri ya TNBC. Ariko ibyo ntibivuze ko idashobora kuvurwa. Hari ubundi buryo bwiza bwo kuvura ibi, kandi tuzabivugaho nyuma.

Ni ibihe bimenyetso by'iyi kanseri?

Ibimenyetso bya kanseri y'ibere ifite ibice bitatu bisa cyane n'iby'izindi kanseri z'ibere. Niba ubonye ikintu kidasanzwe mu mabere yawe, ni ngombwa kwitondera.

Niba ufite kimwe cyangwa byinshi muri ibi bikurikira, nyamuneka ntugatinye ujye kwa muganga vuba bishoboka. Kugira ibi bimenyetso ntibivuze ko ari kanseri, ariko ni byiza kwisuzumisha.

Ibimenyetso Ibisobanuro byoroshye
Ikibyimba gishya cyangwa ububyimba mu ibere Ikintu kimeze nk'ikibyimba kitari cyarigeze kibaho mbere, cyafashwe mu ntoki.
Kubabara mu mabere cyangwa mu mabere Ububabare bukunze kubaho kandi budasobanutse.
Impinduka z'uruhu rw'ibere Uruhu ruhinduka nk'urushinge, gutukura, kubyimba cyangwa kuma, nk'igishishwa cy'umuhondo.
Guhindura intanga Ibere ​​ryari risanzwe rinyura imbere.
Gusohora inshinge Amaraso cyangwa andi mazi ava mu ibere iyo utari umubyeyi wonsa.
Kubyimba amabere Kubyimba kw'ibere, haba burundu cyangwa igice cyaryo.
Utubyimba mu kwaha cyangwa hafi y'igufwa ry'umugongoIbibyimba biterwa no kubyimba kw'uturemangingo tw'imitsi.

Wibuke ko kwisuzumisha kanseri buri gihe bishobora kugaragaza kanseri mbere yuko ibimenyetso bigaragara. Kubwibyo, ni ngombwa cyane kwisuzumisha imyaka ku gihe.

Ni izihe mpamvu n'ibintu bishobora gutera iyi kanseri?

Abashakashatsi ntibarabona impamvu yihariye itera iyi kanseri, ariko basanze hari isano ikomeye hagati yayo n'uturemangingo.

By’umwihariko, hari isano ikomeye hagati y’impinduka mu turemangingo twa BRCA1 na BRCA2 na TNBC. Ubusanzwe, utu turemangingo twa BRCA dufite inshingano zo kugenzura ikura rya kanseri mu mibiri yacu. Kimwe n’uburyo imodoka ikoresha feri. Iyo hari inenge cyangwa impinduka muri utu turemangingo, ubushobozi bwo kugenzura kanseri burabura. Dushobora kuragwa utu turemangingo tw’ababyeyi bacu.

Uretse ibi, hari n'ibindi bintu byinshi byongera ibyago byo kurwara kanseri ya TNBC.

Impamvu y'ibyago Ibisobanuro
Imyaka Ikunze kugaragara cyane ku bagore bakiri bato bari munsi y'imyaka 40. (Ariko ishobora kugaragara mu myaka iyo ari yo yose.)
Impinduka mu ngirabuzimafatizo za BRCA Ingaruka ziba nyinshi cyane cyane iyo habayeho ihinduka ry’uturemangingo twa BRCA1.
Ubwoko/ubwoko Dukurikije ubushakashatsi bwakozwe hirya no hino ku isi, iyi kanseri ikunze kugaragara cyane ku bagore bafite inkomoko muri Afurika cyangwa muri Esipanye.

Ni gute umuganga asuzuma ibi?

Iyo ugiye kwa muganga ku kibyimba cy'ibere, azabanza asuzume amabere yawe. Hanyuma, bazakubaza ibimenyetso byawe. Byongeye kandi, bazagutegeka ibizamini byinshi kugira ngo bemeze ko wanduye.

  • Mammogram: Gusuzuma ibere hakoreshejwe X-ray.
  • Ultrasound y'amabere: Uburyo bukoresha amajwi kugira ngo bufate amashusho y'uturemangingo turi mu ibere.
  • MRI y'ibere: Uburyo bukoresha imbaraga za rukuruzi n'imirasire ya radiyo kugira ngo haboneke amashusho asobanutse neza kandi arambuye.

Niba izi scan zigaragaza kanseri, ikizamini gikurikiraho cy'ingenzi ni biopsy . Ibi bikubiyemo gufata agace gato cyane k'urugingo rw'umubiri ruvuye ku gahu gakekwa hakoreshejwe urushinge ruto hanyuma ukarusuzuma ukoresheje mikorosikopi.

Uburyo bwonyine bwo kwemeza 100% niba ari kanseri cyangwa atari yo. Nanone, uburyo bwonyine bwo kumenya neza niba ari TNBC ni ugusuzuma iki gice cy'umubiri ukareba niba gifite za receptors eshatu twavuze (ER, PR, HER2).

Byongeye kandi, muganga wawe ashobora no kukwohereza gupimwa mu buryo bw'uturemangingo kugira ngo arebe niba hari impinduka mu buryo bw'uturemangingo, nka BRCA. Aya makuru yose akoreshwa mu kumenya aho kanseri yawe igeze no gutegura gahunda ikwiye yo kugufasha.

Ni ubuhe buryo bwo kuvura ibi?

Nubwo hari imbogamizi mu kuvura kanseri ya TNBC, ubu hari uburyo bwinshi bwo kuvura bufite akamaro kanini. Umuganga wawe w’indwara ya kanseri azagusaba uburyo bwiza bwo kuvura bitewe n’uburwayi bwawe.

Uburyo bw'ingenzi bwo kuvura ni ugukuraho ikibyimba cya kanseri binyuze mu kubagwa. Byongeye kandi, bumwe cyangwa bwinshi muri ubu buryo bukurikira bushobora gukoreshwa hamwe.

  • Chimioterapi: Ubu ni bumwe mu buryo bw'ingenzi kandi bufite akamaro kanini bwo kuvura TNBC. Chimioterapi itangwa mbere yo kubagwa kugira ngo igabanye ikibyimba (neoadjuvant chemotherapy) na nyuma yo kubagwa kugira ngo yica uturemangingo twa kanseri dusigaye no gukumira indwara kugaruka (adjuvant chemotherapy).
  • Ubuvuzi bushingiye ku mirasire: Nyuma yo kubagwa, imirasire ifite ingufu nyinshi ijya mu gace kari kagenewe kwica uturemangingo twa kanseri dusigaye.
  • Ubuvuzi bw'imyuka: Ubu ni uburyo bushya bwo kuvura. Bukora mu gukangura ubudahangarwa bw'umubiri wacu kugira ngo bumenye kandi bwibasire uturemangingo twa kanseri. Kuri bamwe mu barwayi ba TNBC, ubu buryo bushobora gutangwa hamwe na chimiotherapie kugira ngo bugere ku musaruro mwiza cyane.
  • Uburyo bwo kuvura hifashishijwe uburyo bwa “Drugs of Cancer”: Ku barwayi ba TNBC bafite BRCA gene mutations, imiti yihariye nka PARP inhibitors irakoreshwa. Iyi miti ikora mu kubangamira ubushobozi bw'uturemangingo twa kanseri bwo kwisana.

Kuri ubu hari igeragezwa ryinshi ry’ubuvuzi riri gukorwa hirya no hino ku isi kuri TNBC. Imiti mishya n’ubuvuzi bushya buri kuvumburwa buri gihe. Kubwibyo, dushobora kugira icyizere cyiza cy’ejo hazaza h’iyi ndwara.

Ibintu byo gutekerezaho nyuma yo kuvurwa

Nyuma yo kubagwa cyangwa ubundi buvuzi, hari igihe hashobora kubaho ingorane. Urugero, igikomere cyo kubagwa gishobora kwandura cyangwa amaraso agatangira kuzura. Kubwibyo, niba ubonye kimwe muri ibi bimenyetso bikurikira, hamagara muganga wawe vuba.

Igihe cyo gushaka inama z'abaganga byihutirwa
Ibimenyetso by'ubwandu

  • Umuriro (uri hejuru ya 38.4°C / 101°F)
  • Amashyira ava mu gikomere
  • Gutukura cyangwa guhinduka ibara ry'uruhu rukikije igikomere

Ibimenyetso by'amaraso yangiritse Kubyimba ukuguru kubabaza, guhumeka bigoranye.
Ingaruka mbi zikabije Niba ingaruka mbi zo kuvurwa (urugero: kuruka, impiswi) zikomeye cyane ku buryo umuntu atabasha kwihanganira.

Ibintu ushobora gukora kugira ngo ukomeze kugira ubuzima bwiza mu gihe cyo kuvurwa

Kuvura kanseri ni ikintu gihangayikisha cyane, haba ku mubiri no mu mutwe. Hari ibintu bike bishobora kugufasha kumva umerewe neza muri iki gihe.

  • Imyitozo ngororamubiri yoroheje: Imyitozo yoroheje nko kugenda n'amaguru na yoga ishobora gufasha kugabanya stress ndetse no guha umubiri wawe imbaraga nyinshi.
  • Indyo nziza: Kurya indyo yuzuye irimo poroteyine zitarimo ibinure byinshi (amafi, inkoko), imbuto, imboga, ibinyamisogwe, n'ibinyampeke byuzuye (umuceri w'umukara, oatmeal). Nywa amazi menshi.
  • Kugumana ibiro byiza: Ubushakashatsi bwagaragaje ko kugumana ibiro byiza bikubereye ari inkunga nziza mu kuvura.
  • Ubufasha mu by'imitekerereze:Ganira n'umuryango wawe n'inshuti zawe za hafi ku byiyumvo byawe, ubwoba bwawe, n'ibiguhangayikishije. Niba bibaye ngombwa, shaka ubufasha bw'umujyanama mu by'ubuzima bwo mu mutwe.

Niba ingaruka mbi zo kuvurwa ari nyinshi, ntugatinye kubibwira itsinda ry’abaganga. Biyemeje kugufasha muri iki gihe kigoye.

Ubutumwa bwo kujyana mu rugo

  • Kanseri y'ibere ifite ibice bitatu (TNBC) ni ubwoko bwihariye bwa kanseri y'ibere butagira receptor eshatu: estrogen, progesterone, na HER2.
  • Bityo rero, uburyo busanzwe bwo kuvura imisemburo n'uburyo bwo kuvura hifashishijwe HER2 ntabwo bigira ingaruka kuri ibi.
  • Niba ubonye impinduka zidasanzwe mu ibere ryawe (ikibyimba, ububabare, impinduka z'uruhu), ntugatinye ujye kwa muganga ako kanya. Uko bigaragaye vuba, niko ubuvuzi bugenda neza.
  • Hari uburyo bwinshi bwo kuvura butanga umusaruro, harimo imiti ivura indwara za kanseri (chimiotherapie), kubaga, kuvura hakoreshejwe imirasire (radiation therapy), ndetse n'uburyo bugezweho bwo kuvura indwara ziterwa n'ubudahangarwa bw'umubiri.
  • Nubwo iyi ari indwara igoye, hamwe n’iterambere ry’ubuvuzi bwa none, hari uburyo bushya bwo kuvura buri gihe. Bityo rero ntucike intege.
  • Izere itsinda ryawe ry’abaganga, subiza ibibazo byabo mu buryo buboneye, kandi ubaze impungenge zawe. Ntabwo uri wenyine muri uru rugendo.

Kanseri y'ibere ifite ingaruka eshatu, TNBC, ibimenyetso bya kanseri y'ibere, gene ya BRCA, chemotherapy, ubuvuzi bwa kanseri, ubuzima bw'abagore
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

Kwipimisha kanseri y'ibere, kwisuzuma no kwirinda byakozwe byoroshye. Kanseri y'ibihaha

Ishyirireho intego ya calorie hanyuma ubare itariki yo kugabanya ibiro.

Kwipimisha kanseri y'ibere, kwisuzuma no kwirinda byakozwe byoroshye. Kanseri y'ibihaha 9 + 4 =
Icyo ugomba kumenya kuri kanseri y'ibere ifite inenge eshatu
Ubuzima bw'abagore2026 Nyakanga 15

Icyo ugomba kumenya kuri kanseri y'ibere ifite inenge eshatu

Ni ibisanzwe ko umuntu wese agira ubwoba gato iyo yumvise ijambo kanseri y'ibere. Ariko icy'ingenzi tugomba kumenya ni uko kanseri y'ibere yose atari imwe. Hari ubwoko butandukanye bwayo. Uyu munsi tugiye kuvuga ku bwoko bukunze kugaragara cyane kandi busaba kwitabwaho by'umwihariko mu gihe cyo kuvurwa. Iyi tuyita 'Kanseri y'ibere itatu' (TNBC mu magambo ahinnye). Kumva iri zina bishobora kumvikana nk'ibintu bigoye kuri wewe, ariko ntutinye. Tuzabivugaho mu buryo bworoshye, mu buryo ushobora kumva.

Kuki ibi byitwa 'Inyangingo eshatu'?

Reka dutangire n'icyo iri zina risobanura. Kugira ngo tubisobanukirwe, tugomba kugira igitekerezo gito ku buryo uturemangingo tusanzwe twa kanseri y'ibere dukora.

Tekereza ko uturemangingo mu mubiri wacu tumeze nk'inzugi. Izo nzugi zifite ingufuri zifata imfunguzo. Mu buvuzi, izi mfunguzo tuzita 'receptors'. Iyo imfunguzo zihuye n'izi mpuruza zije zigahuza, utwo turemangingo twakira ubutumwa runaka.

Hari ubwoko butatu bw'udukingirizo tw'umubiri (receptors) ingenzi cyane cyane muri kanseri y'ibere.

1. Uturemangingo twa Estrogen (ER): Ibi bifitanye isano na hormone ya estrogen y'abagore.

2. Uturemangingo twa Progesterone (PR): Ibi bifitanye isano n'indi misemburo y'abagore yitwa progesterone.

3. Utunyangingo twa HER2: Iyi ni receptor ifatana na poroteyine yitwa HER2. Iyi poroteyine igenzura imikurire y'uturemangingo tw'ibere.

Mu bwoko bwinshi bwa kanseri y'ibere, imwe, ebyiri, cyangwa eshatu muri izi receptor ziba nyinshi cyane. Ibi bivuze ko izi hormone na poroteyine bifasha uturemangingo twa kanseri gukura. Ni nko kongeramo ibicanwa ku muriro. Rero iyo abaganga bavura izi kanseri, bibanda kuri izi receptor bakayiha imiti izibuza (ubuvuzi bugamije). Iyi miti ifunga izo 'mfunguzo'. Hanyuma uturemangingo twa kanseri ntitwongera kubona ubutumwa dukeneye kugira ngo dukure.

Mu magambo make, 'triple-negative' bivuze ko utwo turemangingo twa kanseri tudafite resepteur eshatu zavuzwe haruguru (estrogen, progesterone, na HER2) . 'Negative' bivuze 'oya'. Ni 'triple-negative' kuko idafite zose uko ari eshatu.

Noneho ushobora kuba usobanukiwe aho ikibazo kiri? Imiti isanzwe yibasira receptor ntabwo ikora kuri ubwo bwoko bwa kanseri. Kuko nta receptor igomba kwibasira. Iki ni cyo kibazo gikomeye kuri kanseri ya TNBC. Ariko ibyo ntibivuze ko idashobora kuvurwa. Hari ubundi buryo bwiza bwo kuvura ibi, kandi tuzabivugaho nyuma.

Ni ibihe bimenyetso by'iyi kanseri?

Ibimenyetso bya kanseri y'ibere ifite ibice bitatu bisa cyane n'iby'izindi kanseri z'ibere. Niba ubonye ikintu kidasanzwe mu mabere yawe, ni ngombwa kwitondera.

Niba ufite kimwe cyangwa byinshi muri ibi bikurikira, nyamuneka ntugatinye ujye kwa muganga vuba bishoboka. Kugira ibi bimenyetso ntibivuze ko ari kanseri, ariko ni byiza kwisuzumisha.

Ibimenyetso Ibisobanuro byoroshye
Ikibyimba gishya cyangwa ububyimba mu ibere Ikintu kimeze nk'ikibyimba kitari cyarigeze kibaho mbere, cyafashwe mu ntoki.
Kubabara mu mabere cyangwa mu mabere Ububabare bukunze kubaho kandi budasobanutse.
Impinduka z'uruhu rw'ibere Uruhu ruhinduka nk'urushinge, gutukura, kubyimba cyangwa kuma, nk'igishishwa cy'umuhondo.
Guhindura intanga Ibere ​​ryari risanzwe rinyura imbere.
Gusohora inshinge Amaraso cyangwa andi mazi ava mu ibere iyo utari umubyeyi wonsa.
Kubyimba amabere Kubyimba kw'ibere, haba burundu cyangwa igice cyaryo.
Utubyimba mu kwaha cyangwa hafi y'igufwa ry'umugongoIbibyimba biterwa no kubyimba kw'uturemangingo tw'imitsi.

Wibuke ko kwisuzumisha kanseri buri gihe bishobora kugaragaza kanseri mbere yuko ibimenyetso bigaragara. Kubwibyo, ni ngombwa cyane kwisuzumisha imyaka ku gihe.

Ni izihe mpamvu n'ibintu bishobora gutera iyi kanseri?

Abashakashatsi ntibarabona impamvu yihariye itera iyi kanseri, ariko basanze hari isano ikomeye hagati yayo n'uturemangingo.

By’umwihariko, hari isano ikomeye hagati y’impinduka mu turemangingo twa BRCA1 na BRCA2 na TNBC. Ubusanzwe, utu turemangingo twa BRCA dufite inshingano zo kugenzura ikura rya kanseri mu mibiri yacu. Kimwe n’uburyo imodoka ikoresha feri. Iyo hari inenge cyangwa impinduka muri utu turemangingo, ubushobozi bwo kugenzura kanseri burabura. Dushobora kuragwa utu turemangingo tw’ababyeyi bacu.

Uretse ibi, hari n'ibindi bintu byinshi byongera ibyago byo kurwara kanseri ya TNBC.

Impamvu y'ibyago Ibisobanuro
Imyaka Ikunze kugaragara cyane ku bagore bakiri bato bari munsi y'imyaka 40. (Ariko ishobora kugaragara mu myaka iyo ari yo yose.)
Impinduka mu ngirabuzimafatizo za BRCA Ingaruka ziba nyinshi cyane cyane iyo habayeho ihinduka ry’uturemangingo twa BRCA1.
Ubwoko/ubwoko Dukurikije ubushakashatsi bwakozwe hirya no hino ku isi, iyi kanseri ikunze kugaragara cyane ku bagore bafite inkomoko muri Afurika cyangwa muri Esipanye.

Ni gute umuganga asuzuma ibi?

Iyo ugiye kwa muganga ku kibyimba cy'ibere, azabanza asuzume amabere yawe. Hanyuma, bazakubaza ibimenyetso byawe. Byongeye kandi, bazagutegeka ibizamini byinshi kugira ngo bemeze ko wanduye.

  • Mammogram: Gusuzuma ibere hakoreshejwe X-ray.
  • Ultrasound y'amabere: Uburyo bukoresha amajwi kugira ngo bufate amashusho y'uturemangingo turi mu ibere.
  • MRI y'ibere: Uburyo bukoresha imbaraga za rukuruzi n'imirasire ya radiyo kugira ngo haboneke amashusho asobanutse neza kandi arambuye.

Niba izi scan zigaragaza kanseri, ikizamini gikurikiraho cy'ingenzi ni biopsy . Ibi bikubiyemo gufata agace gato cyane k'urugingo rw'umubiri ruvuye ku gahu gakekwa hakoreshejwe urushinge ruto hanyuma ukarusuzuma ukoresheje mikorosikopi.

Uburyo bwonyine bwo kwemeza 100% niba ari kanseri cyangwa atari yo. Nanone, uburyo bwonyine bwo kumenya neza niba ari TNBC ni ugusuzuma iki gice cy'umubiri ukareba niba gifite za receptors eshatu twavuze (ER, PR, HER2).

Byongeye kandi, muganga wawe ashobora no kukwohereza gupimwa mu buryo bw'uturemangingo kugira ngo arebe niba hari impinduka mu buryo bw'uturemangingo, nka BRCA. Aya makuru yose akoreshwa mu kumenya aho kanseri yawe igeze no gutegura gahunda ikwiye yo kugufasha.

Ni ubuhe buryo bwo kuvura ibi?

Nubwo hari imbogamizi mu kuvura kanseri ya TNBC, ubu hari uburyo bwinshi bwo kuvura bufite akamaro kanini. Umuganga wawe w’indwara ya kanseri azagusaba uburyo bwiza bwo kuvura bitewe n’uburwayi bwawe.

Uburyo bw'ingenzi bwo kuvura ni ugukuraho ikibyimba cya kanseri binyuze mu kubagwa. Byongeye kandi, bumwe cyangwa bwinshi muri ubu buryo bukurikira bushobora gukoreshwa hamwe.

  • Chimioterapi: Ubu ni bumwe mu buryo bw'ingenzi kandi bufite akamaro kanini bwo kuvura TNBC. Chimioterapi itangwa mbere yo kubagwa kugira ngo igabanye ikibyimba (neoadjuvant chemotherapy) na nyuma yo kubagwa kugira ngo yica uturemangingo twa kanseri dusigaye no gukumira indwara kugaruka (adjuvant chemotherapy).
  • Ubuvuzi bushingiye ku mirasire: Nyuma yo kubagwa, imirasire ifite ingufu nyinshi ijya mu gace kari kagenewe kwica uturemangingo twa kanseri dusigaye.
  • Ubuvuzi bw'imyuka: Ubu ni uburyo bushya bwo kuvura. Bukora mu gukangura ubudahangarwa bw'umubiri wacu kugira ngo bumenye kandi bwibasire uturemangingo twa kanseri. Kuri bamwe mu barwayi ba TNBC, ubu buryo bushobora gutangwa hamwe na chimiotherapie kugira ngo bugere ku musaruro mwiza cyane.
  • Uburyo bwo kuvura hifashishijwe uburyo bwa “Drugs of Cancer”: Ku barwayi ba TNBC bafite BRCA gene mutations, imiti yihariye nka PARP inhibitors irakoreshwa. Iyi miti ikora mu kubangamira ubushobozi bw'uturemangingo twa kanseri bwo kwisana.

Kuri ubu hari igeragezwa ryinshi ry’ubuvuzi riri gukorwa hirya no hino ku isi kuri TNBC. Imiti mishya n’ubuvuzi bushya buri kuvumburwa buri gihe. Kubwibyo, dushobora kugira icyizere cyiza cy’ejo hazaza h’iyi ndwara.

Ibintu byo gutekerezaho nyuma yo kuvurwa

Nyuma yo kubagwa cyangwa ubundi buvuzi, hari igihe hashobora kubaho ingorane. Urugero, igikomere cyo kubagwa gishobora kwandura cyangwa amaraso agatangira kuzura. Kubwibyo, niba ubonye kimwe muri ibi bimenyetso bikurikira, hamagara muganga wawe vuba.

Igihe cyo gushaka inama z'abaganga byihutirwa
Ibimenyetso by'ubwandu

  • Umuriro (uri hejuru ya 38.4°C / 101°F)
  • Amashyira ava mu gikomere
  • Gutukura cyangwa guhinduka ibara ry'uruhu rukikije igikomere

Ibimenyetso by'amaraso yangiritse Kubyimba ukuguru kubabaza, guhumeka bigoranye.
Ingaruka mbi zikabije Niba ingaruka mbi zo kuvurwa (urugero: kuruka, impiswi) zikomeye cyane ku buryo umuntu atabasha kwihanganira.

Ibintu ushobora gukora kugira ngo ukomeze kugira ubuzima bwiza mu gihe cyo kuvurwa

Kuvura kanseri ni ikintu gihangayikisha cyane, haba ku mubiri no mu mutwe. Hari ibintu bike bishobora kugufasha kumva umerewe neza muri iki gihe.

  • Imyitozo ngororamubiri yoroheje: Imyitozo yoroheje nko kugenda n'amaguru na yoga ishobora gufasha kugabanya stress ndetse no guha umubiri wawe imbaraga nyinshi.
  • Indyo nziza: Kurya indyo yuzuye irimo poroteyine zitarimo ibinure byinshi (amafi, inkoko), imbuto, imboga, ibinyamisogwe, n'ibinyampeke byuzuye (umuceri w'umukara, oatmeal). Nywa amazi menshi.
  • Kugumana ibiro byiza: Ubushakashatsi bwagaragaje ko kugumana ibiro byiza bikubereye ari inkunga nziza mu kuvura.
  • Ubufasha mu by'imitekerereze:Ganira n'umuryango wawe n'inshuti zawe za hafi ku byiyumvo byawe, ubwoba bwawe, n'ibiguhangayikishije. Niba bibaye ngombwa, shaka ubufasha bw'umujyanama mu by'ubuzima bwo mu mutwe.

Niba ingaruka mbi zo kuvurwa ari nyinshi, ntugatinye kubibwira itsinda ry’abaganga. Biyemeje kugufasha muri iki gihe kigoye.

Ubutumwa bwo kujyana mu rugo

  • Kanseri y'ibere ifite ibice bitatu (TNBC) ni ubwoko bwihariye bwa kanseri y'ibere butagira receptor eshatu: estrogen, progesterone, na HER2.
  • Bityo rero, uburyo busanzwe bwo kuvura imisemburo n'uburyo bwo kuvura hifashishijwe HER2 ntabwo bigira ingaruka kuri ibi.
  • Niba ubonye impinduka zidasanzwe mu ibere ryawe (ikibyimba, ububabare, impinduka z'uruhu), ntugatinye ujye kwa muganga ako kanya. Uko bigaragaye vuba, niko ubuvuzi bugenda neza.
  • Hari uburyo bwinshi bwo kuvura butanga umusaruro, harimo imiti ivura indwara za kanseri (chimiotherapie), kubaga, kuvura hakoreshejwe imirasire (radiation therapy), ndetse n'uburyo bugezweho bwo kuvura indwara ziterwa n'ubudahangarwa bw'umubiri.
  • Nubwo iyi ari indwara igoye, hamwe n’iterambere ry’ubuvuzi bwa none, hari uburyo bushya bwo kuvura buri gihe. Bityo rero ntucike intege.
  • Izere itsinda ryawe ry’abaganga, subiza ibibazo byabo mu buryo buboneye, kandi ubaze impungenge zawe. Ntabwo uri wenyine muri uru rugendo.

Kanseri y'ibere ifite ingaruka eshatu, TNBC, ibimenyetso bya kanseri y'ibere, gene ya BRCA, chemotherapy, ubuvuzi bwa kanseri, ubuzima bw'abagore
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

Kwipimisha kanseri y'ibere, kwisuzuma no kwirinda byakozwe byoroshye. Kanseri y'ibihaha

Ishyirireho intego ya calorie hanyuma ubare itariki yo kugabanya ibiro.

Kwipimisha kanseri y'ibere, kwisuzuma no kwirinda byakozwe byoroshye. Kanseri y'ibihaha 9 + 4 =